On the other hand, evidences suggest that immuno-related pro-inflammatory cytokines, such as IL-1, IL-6, and IL-17, and tumor-derived chemokines may determine an augmented VEGF production with the aforementioned results. The gene discussed is IL17A; the disease is neoplasm.